211 related articles for article (PubMed ID: 21326223)
1. Methylation of NEUROG1 in serum is a sensitive marker for the detection of early colorectal cancer.
Herbst A; Rahmig K; Stieber P; Philipp A; Jung A; Ofner A; Crispin A; Neumann J; Lamerz R; Kolligs FT
Am J Gastroenterol; 2011 Jun; 106(6):1110-8. PubMed ID: 21326223
[TBL] [Abstract][Full Text] [Related]
2. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
3. A combination of serum markers for the early detection of colorectal cancer.
Wild N; Andres H; Rollinger W; Krause F; Dilba P; Tacke M; Karl J
Clin Cancer Res; 2010 Dec; 16(24):6111-21. PubMed ID: 20798228
[TBL] [Abstract][Full Text] [Related]
4. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
[TBL] [Abstract][Full Text] [Related]
5. Methylation of serum DNA is an independent prognostic marker in colorectal cancer.
Wallner M; Herbst A; Behrens A; Crispin A; Stieber P; Göke B; Lamerz R; Kolligs FT
Clin Cancer Res; 2006 Dec; 12(24):7347-52. PubMed ID: 17189406
[TBL] [Abstract][Full Text] [Related]
6. Analysis of DNA methylation in bowel lavage fluid for detection of colorectal cancer.
Harada T; Yamamoto E; Yamano HO; Nojima M; Maruyama R; Kumegawa K; Ashida M; Yoshikawa K; Kimura T; Harada E; Takagi R; Tanaka Y; Aoki H; Nishizono M; Nakaoka M; Tsuyada A; Niinuma T; Kai M; Shimoda K; Shinomura Y; Sugai T; Imai K; Suzuki H
Cancer Prev Res (Phila); 2014 Oct; 7(10):1002-10. PubMed ID: 25139296
[TBL] [Abstract][Full Text] [Related]
7. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
[TBL] [Abstract][Full Text] [Related]
8. Molecular detection of circulating cancer cells in the peripheral blood of patients with colorectal cancer by using membrane array with a multiple mRNA marker panel.
Yeh CS; Wang JY; Wu CH; Chong IW; Chung FY; Wang YH; Yu YP; Lin SR
Int J Oncol; 2006 Feb; 28(2):411-20. PubMed ID: 16391796
[TBL] [Abstract][Full Text] [Related]
9. Methylation of helicase-like transcription factor in serum of patients with colorectal cancer is an independent predictor of disease recurrence.
Herbst A; Wallner M; Rahmig K; Stieber P; Crispin A; Lamerz R; Kolligs FT
Eur J Gastroenterol Hepatol; 2009 May; 21(5):565-9. PubMed ID: 19282772
[TBL] [Abstract][Full Text] [Related]
10. Detection of TFPI2 methylation in the serum of colorectal cancer patients.
Hibi K; Goto T; Shirahata A; Saito M; Kigawa G; Nemoto H; Sanada Y
Cancer Lett; 2011 Dec; 311(1):96-100. PubMed ID: 21820798
[TBL] [Abstract][Full Text] [Related]
11. Identification of Cystatin SN as a novel tumor marker for colorectal cancer.
Yoneda K; Iida H; Endo H; Hosono K; Akiyama T; Takahashi H; Inamori M; Abe Y; Yoneda M; Fujita K; Kato S; Nozaki Y; Ichikawa Y; Uozaki H; Fukayama M; Shimamura T; Kodama T; Aburatani H; Miyazawa C; Ishii K; Hosomi N; Sagara M; Takahashi M; Ike H; Saito H; Kusakabe A; Nakajima A
Int J Oncol; 2009 Jul; 35(1):33-40. PubMed ID: 19513549
[TBL] [Abstract][Full Text] [Related]
12. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
Guadagni F; Kantor J; Aloe S; Carone MD; Spila A; D'Alessandro R; Abbolito MR; Cosimelli M; Graziano F; Carboni F; Carlini S; Perri P; Sciarretta F; Greiner JW; Kashmiri SV; Steinberg SM; Roselli M; Schlom J
Cancer Res; 2001 Mar; 61(6):2523-32. PubMed ID: 11289125
[TBL] [Abstract][Full Text] [Related]
13. CpG island hypermethylation of cell-free circulating serum DNA in patients with testicular cancer.
Ellinger J; Albers P; Perabo FG; Müller SC; von Ruecker A; Bastian PJ
J Urol; 2009 Jul; 182(1):324-9. PubMed ID: 19447423
[TBL] [Abstract][Full Text] [Related]
14. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
[TBL] [Abstract][Full Text] [Related]
15. Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening.
Ng EK; Chong WW; Jin H; Lam EK; Shin VY; Yu J; Poon TC; Ng SS; Sung JJ
Gut; 2009 Oct; 58(10):1375-81. PubMed ID: 19201770
[TBL] [Abstract][Full Text] [Related]
16. Detection in fecal DNA of colon cancer-specific methylation of the nonexpressed vimentin gene.
Chen WD; Han ZJ; Skoletsky J; Olson J; Sah J; Myeroff L; Platzer P; Lu S; Dawson D; Willis J; Pretlow TP; Lutterbaugh J; Kasturi L; Willson JK; Rao JS; Shuber A; Markowitz SD
J Natl Cancer Inst; 2005 Aug; 97(15):1124-32. PubMed ID: 16077070
[TBL] [Abstract][Full Text] [Related]
17. [Fecal methylated DNA for the detection of colorectal cancer].
von Delius S; Jung A; Schmid RM
Z Gastroenterol; 2006 Sep; 44(9):1001-2. PubMed ID: 16981074
[No Abstract] [Full Text] [Related]
18. Detection of aberrant p16 methylation in the serum of colorectal cancer patients.
Zou HZ; Yu BM; Wang ZW; Sun JY; Cang H; Gao F; Li DH; Zhao R; Feng GG; Yi J
Clin Cancer Res; 2002 Jan; 8(1):188-91. PubMed ID: 11801557
[TBL] [Abstract][Full Text] [Related]
19. Detection of methylated tissue factor pathway inhibitor 2 and human long DNA in fecal samples of patients with colorectal cancer in China.
Zhang J; Yang S; Xie Y; Chen X; Zhao Y; He D; Li J
Cancer Epidemiol; 2012 Feb; 36(1):73-7. PubMed ID: 21621497
[TBL] [Abstract][Full Text] [Related]
20. DNA methylation biomarkers for noninvasive diagnosis of colorectal cancer.
Carmona FJ; Azuara D; Berenguer-Llergo A; Fernández AF; Biondo S; de Oca J; Rodriguez-Moranta F; Salazar R; Villanueva A; Fraga MF; Guardiola J; Capellá G; Esteller M; Moreno V
Cancer Prev Res (Phila); 2013 Jul; 6(7):656-65. PubMed ID: 23694962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
